Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hammer Imaging is a medical technology company specializing in the development of high-resolution, dedicated brain Positron Emission Tomography (PET) scanners. Spun out of research from the University of Pennsylvania, the company aims to provide significantly higher spatial resolution and sensitivity compared to conventional whole-body PET systems. Their technology is designed to improve the early detection and monitoring of neurodegenerative diseases such as Alzheimer's and Parkinson's, as well as brain tumors and traumatic brain injuries. By focusing on a compact, cost-effective design, Hammer Imaging seeks to make advanced molecular imaging more accessible for clinical and research applications. The company's core innovation lies in its optimized detector geometry and advanced reconstruction algorithms tailored specifically for the human brain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hammer Imaging.